4.7 Article

Genetic Imbalance Is Associated With Functional Outcome After Ischemic Stroke

Journal

STROKE
Volume 50, Issue 2, Pages 298-304

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1161/STROKEAHA.118.021856

Keywords

DNA copy number variations; genetics; polymorphism, single nucleotide; prognosis; stroke

Funding

  1. Inserm, Lille 2 University, Institut Pasteur de Lille and Lille University Hospital
  2. Contrat de Projet Etat-Region 2007 Region Nord-Pas-de-Calais
  3. Centre National de Genotypage
  4. Emil Aaltonen Foundation
  5. Paavo Ilmari Ahvenainen Foundation
  6. Helsinki University Central Hospital Research Fund
  7. Academy of Finland
  8. Helsinki University Medical Foundation
  9. Paivikki and Sakari Sohlberg Foundation
  10. Aarne Koskelo Foundation
  11. Maire Taponen Foundation
  12. Aarne and Aili Turunen Foundation
  13. Lilly Foundation
  14. Alfred Kordelin Foundation
  15. Finnish Medical Foundation
  16. Biomedicum Helsinki Foundation
  17. Maud Kuistila Foundation
  18. Orion-Farmos Research Foundation
  19. Finnish Brain Foundation
  20. Projet Hospitalier de Recherche Clinique Regional
  21. Fondation de France
  22. Genopole de Lille
  23. Kathe-Zingg-Schwichtenberg-Fonds of the Swiss Academy of Medical Sciences
  24. Swiss National Science Foundation [33CM30-124119, 33CM30-140340/1]
  25. Swiss Heart Foundation
  26. University of Basel
  27. Fonds voor Wetenschappelijk Onderzoek (FWO) Vlaanderen (Research Foundation-Flanders) - US National Institute of Neurological Disorders and Stroke, National Institutes of Health [U01 NS069208, pp 159-170]
  28. National Institutes of Health (NIH) [R01-NS100178, R01-NS105150]
  29. US Department of Veterans Affairs
  30. American Heart Association (AHA) Cardiovascular Genome-Phenome Study (Grant15GPSPG23770000) [Grant17IBDG33700328]
  31. Swedish Research Council [K2014-64X-14605-12-5]
  32. Swedish state and Region Vastra Gotaland [ALFGBG-429981]
  33. Swedish Heart and Lung Foundation
  34. Swedish Stroke Association - Region Skane, Lund University
  35. Freemasons Lodge of Instruction Eos Lund
  36. Skane University Hospital
  37. Foundation of FarsAMP
  38. Frostaone of Sparbanken Skane's ownership Foundations
  39. Swedish Stroke Association - German Research Foundation (DFG) through the Cluster of Excellence [306]

Ask authors/readers for more resources

Background and Purpose-We sought to explore the effect of genetic imbalance on functional outcome after ischemic stroke (IS). Methods-Copy number variation was identified in high-density single-nucleotide polymorphism microarray data of IS patients from the CADISP (Cervical Artery Dissection and Ischemic Stroke Patients) and SiGN (Stroke Genetics Network)/ GISCOME (Genetics of Ischaemic Stroke Functional Outcome) networks. Genetic imbalance, defined as total number of protein-coding genes affected by copy number variations in an individual, was compared between patients with favorable (modified Rankin Scale score of 0-2) and unfavorable (modified Rankin Scale score of = 3) outcome after 3 months. Subgroup analyses were confined to patients with imbalance affecting ohnologs-a class of dose-sensitive genes, or to those with imbalance not affecting ohnologs. The association of imbalance with outcome was analyzed by logistic regression analysis, adjusted for age, sex, stroke subtype, stroke severity, and ancestry. Results-The study sample comprised 816 CADISP patients (age 44.2 +/- 10.3 years) and 2498 SiGN/GISCOME patients (age 67.7 +/- 14.2 years). Outcome was unfavorable in 122 CADISP and 889 SiGN/GISCOME patients. Multivariate logistic regression analysis revealed that increased genetic imbalance was associated with less favorable outcome in both samples (CADISP: P=0.0007; odds ratio=0.89; 95% CI, 0.82-0.95 and SiGN/GISCOME: P=0.0036; odds ratio=0.94; 95% CI, 0.91-0.98). The association was independent of age, sex, stroke severity on admission, stroke subtype, and ancestry. On subgroup analysis, imbalance affecting ohnologs was associated with outcome (CADISP: odds ratio=0.88; 95% CI, 0.80-0.95 and SiGN/GISCOME: odds ratio=0.93; 95% CI, 0.89-0.98) whereas imbalance without ohnologs lacked such an association. Conclusions-Increased genetic imbalance was associated with poorer functional outcome after IS in both study populations. Subgroup analysis revealed that this association was driven by presence of ohnologs in the respective copy number variations, suggesting a causal role of the deleterious effects of genetic imbalance.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Clinical Neurology

Epigenetic and integrative cross-omics analyses of cerebral white matter hyperintensities on MRI

Yunju Yang, Maria J. Knol, Ruiqi Wang, Aniket Mishra, Dan Liu, Michelle Luciano, Alexander Teumer, Nicola Armstrong, Joshua C. Bis, Min A. Jhun, Shuo Li, Hieab H. H. Adams, Nasir Ahmad Aziz, Mark E. Bastin, Mathieu Bourgey, Jennifer A. Smith, Stefan Frenzel, Rebecca F. Gottesman, Norbert Hosten, Lifang Hou, Sharon L. R. Kardia, Valerie Lohner, Pascale Marquis, Susana Munoz Maniega, Claudia L. Satizabal, Farzaneh A. Sorond, Maria C. Valdes Hernandez, Cornelia M. van Duijn, Meike W. Vernooij, Katharina Wittfeld, Qiong Yang, Wei Zhao, Eric Boerwinkle, Daniel Levy, Ian J. Deary, Jiyang Jiang, Karen A. Mather, Thomas H. Mosley, Bruce M. Psaty, Perminder S. Sachdev, Jennifer A. Smith, Nona Sotoodehnia, Charles S. DeCarli, Monique M. B. Breteler, M. Arfan Ikram, Hans J. Grabe, Joanna Wardlaw, W. T. Longstreth, Lenore J. Launer, Sudha Seshadri, Stephanie Debette, Myriam Fornage

Summary: This study investigates the association between epigenetic changes and white matter hyperintensities in adults. The findings suggest that blood-brain barrier dysfunction and the immune response are related to white matter hyperintensity burden, and antihyperlipidemic agents might be a potential treatment.

BRAIN (2023)

Article Clinical Neurology

Effects of Direct Oral Anticoagulants' Nonrecommended Dose in Atrial Fibrillation: A Meta-Analysis

Maria Giulia Mosconi, Giorgio Maraziti, Maurizio Paciaroni, Michela Giustozzi, Maria Cristina Vedovati, Giulio Bogliari, Chiara Urbini, Laura Traballi, Valeria Caso

Summary: Compared with recommended doses, nonrecommended low doses of DOACs increase the risk of ischemic events without decreasing the risk of bleeding. For Asians, the efficacy of DOACs seemed preserved despite the nonrecommended low-dose prescription. Clinicians should carefully adhere to recommended DOAC prescription advice in managing NVAF patients.

EUROPEAN NEUROLOGY (2023)

Article Clinical Neurology

Ischaemic cerebral small vessel disease caused by adenosine deaminase 2 deficiency syndrome

Alessia Giossi, Silvia Clara Giliani, Massimo Gamba, Paola Toniati, Mauro Magoni, Alessandro Pezzini

Summary: This article describes a case of an adult patient with recurrent acute ischemic strokes due to cerebral small vessel disease (cSVD), without any other phenotypic manifestations. Targeted next-generation sequencing detected a pathogenic missense variant in the ADA2 gene (c.139G > A, p.G47R), consistent with the diagnosis of adenosine deaminase 2 deficiency syndrome. The findings highlight the diagnostic potential of next-generation sequencing for identifying genetic causes in stroke patients with atypical presentations of cSVD.

EUROPEAN JOURNAL OF NEUROLOGY (2023)

Editorial Material Clinical Neurology

Brain-specific biomarkers: on the winding path to accessibility and clinical relevance

Radu Tanasescu, Didier Leys

EUROPEAN JOURNAL OF NEUROLOGY (2023)

Article Clinical Neurology

Safety and Outcome of Revascularization Treatment in Patients With Acute Ischemic Stroke and COVID-19 The Global COVID-19 Stroke Registry

Joao Pedro Marto, Davide N. Strambo, George Ntaios, Thanh Nguyen, Roman Herzig, Anna Czlonkowska, Jelle Demeestere, Ossama Yassin Mansour, Alexander Salerno, Susanne W. Wegener, Philipp Baumgartner, Carlo Cereda, Giovanni Bianco, Morin Beyeler, Marcel Arnold, Emmanuel Carrera, Paolo Machi, Valerian Altersberger, Leo Bonati, Henrik Gensicke, Manuel Bolognese, Nils Peters, Stephan Wetzel, Marta Magrico, Joao Nuno Ramos, Joao Sargento-Freitas, Rita Machado, Carolina Maia, Egidio Machado, Ana Paiva Nunes, Patricia Ferreira, Teresa Pinho e Melo, Mariana Carvalho Dias, Andre Paula, Manuel Alberto Correia, Pedro Castro, Elsa Azevedo, Luis Albuquerque, Jose Nuno Alves, Joana Ferreira-Pinto, Torcato Meira, Liliana Pereira, Miguel Rodrigues, Andre Pinho Araujo, Marta Rodrigues, Mariana Rocha, Angelo Pereira-Fonseca, Luis Ribeiro, Ricardo Varela, Sofia Malheiro, Manuel Cappellari, Cecilia Zivelonghi, Giulia Sajeva, Andrea Zini, Mauro Gentile, Stefano Forlivesi, Ludovica Migliaccio, Maria Sessa, Sara La Gioia, Alessandro Pezzini, Davide Sangalli, Marialuisa Zedde, Rosario Pascarella, Carlo Ferrarese, Simone Beretta, Susanna Diamanti, Ghil Schwarz, Giovanni Frisullo, Simona Marcheselli, Pierre Seners, Candice Sabben, Simon Escalard, Michel Piotin, Benjamin Maier, Guillaume Charbonnier, Fabrice Vuillier, Loic R. Legris, Pauline Cuisenier, Francesca Vodret, Gaultier Marnat, Jean-Sebastien Liegey, Igor Sibon, Fabian Flottmann, Gabriel O. Broocks, Nils-Ole Gloyer, Ferdinand Bohmann, Jan Hendrik J. Schaefer, Christian Nolte, Heinrich Audebert, Eberhard Siebert, Marek Sykora, Wilfried Lang, Julia Ferrari, Lukas Mayer-Suess, Michael Knoflach, Elke Ruth J. Gizewski, Jeffrey M. Stolp, Lotte Stolze, Jonathan Coutinho, Paul Nederkoorn, Ido van den Wijngaard, Joke De Meris, Robin Lemmens, Sylvie De Raedt, Fenne Vandervorst, Matthieu Pierre Rutgers, Antoine Guilmot, Anne Dusart, Flavio Bellante, Patricia Calleja-Castano, Fernando Ostos, Guillermo Gonzalez-Ortega, Paloma Martin-Jimenez, Sebastian Garcia-Madrona, Antonio Cruz-Culebras, Rocio Vera, Maria Consuelo Matute, Blanca Fuentes, Maria Alonso-de-Lecinana, Ricardo Rigual, Exuperio Diez-Tejedor, Soledad Perez-Sanchez, Joan Montaner, Fernando Diaz-Otero, Natalia Perez-de-la-Ossa, Belen Flores-Pina, Lucia Munoz-Narbona, Angel Chamorro, Alejandro Rodriguez-Vazquez, Arturo Renu, Oscar Ayo-Martin, Francisco Hernandez-Fernandez, Tomas Segura, Herbert Tejada-Meza, Daniel Sagarra-Mur, Marta Serrano-Ponz, Thant Hlaing, Isaiah See, Robert Simister, David Werring, Espen Saxhaug Kristoffersen, Annika Nordanstig, Katarina Jood, Alexandros Rentzos, Libor Simunek, Dagmar Krajickova, Antonin Krajina, Robert Mikulik, Martina Cvikova, Jan Vinklarek, David Skoloudik, Martin Roubec, Eva Hurtikova, Rostislav Hruby, Svatopluk Ostry, Ondrej Skoda, Marek Pernicka, Lubomir Jurak, Zuzana Eichlova, Martin Jira, Martin Kovar, Michal Pansky, Pavel Mencl, Hana Palouskova, Ales Tomek, Petr Jansky, Anna Olserova, Martin Sramek, Roman Havlicek, Petr Maly, Lukas Trakal, Jan Fiksa, Matej Slovak, Michal Adam Karlinski, Maciej Nowak, Halina Sienkiewicz-Jarosz, Anna Bochynska, Pawel Wrona, Tomasz Homa, Katarzyna Sawczynska, Agnieszka Slowik, Ewa Wlodarczyk, Marcin Wiacek, Izabella Tomaszewska-Lampart, Bartosz Sieczkowski, Halina Bartosik-Psujek, Marta Bilik, Anna Bandzarewicz, Malgorzata Dorobek, Justyna Zielinska-Turek, Marta Nowakowska-Kotas, Krystian Obara, Pawel Urbanowski, Slawomir Budrewicz, Maciej Guzinski, Milena Switonska, Iwona Rutkowska, Paulina M. Sobieszak-Skura, Beata Labuz-Roszak, Aleksander Debiec, Jacek Staszewski, Adam Stepien, Jacek Zwiernik, Grzegorz Wasilewski, Cristina Tiu, Elena Oana Terecoasa, Razvan Alexandru Radu, Anca Negrila, Bogdan Dorobat, Cristina Panea, Vlad Tiu, Simona Petrescu, Atilla Ozdemir, Mostafa Mahmoud, Hussam El-Samahy, Hazem Abdelkhalek, Jasem Al-Hashel, Ismail Ibrahim Ismail, Athari Salmeen, Abdoreza Ghoreishi, Sergiu Ionut Sabetay, Hana Gross, Piers Klein, Mohamad Abdalkader, Pascal Jabbour, Kareem El Naamani, Stavropoula Tjoumakaris, Rawad A. Abbas, Ghada Mohamed, Alex Chebl, Jiangyong Min, Majesta P. Hovingh, Jenney Tsai, Muhib Khan, Krishna Nalleballe, Sanjeeva Onteddu, Hesham Masoud, Mina Michael, Navreet Kaur, Laith G. Maali, Michael Abraham, Priyank Khandelwal, Ivo Bach, Melody Ong, Denis M. Babici, Ayaz Khawaja, Maryam Hakemi, Kumar Rajamani, Vanessa Cano-Nigenda, Antonio Arauz, Pablo Amaya, Natalia Llanos, Akemi Arango, Miguel Angel Vences, Jose Dominguo Barrientos Guerra, Rayllene Caetano, Rodrigo Targa Martins, Sergio Daniel Scollo, Patrick Matic Yalung, Shashank Nagendra, Abhijit Gaikwad, Kwon-Duk Seo, Georgios G. Georgiopoulos, Raul Nogueira, Patrik Michel

Summary: This retrospective study evaluated the safety and outcomes of revascularization treatments in patients with acute ischemic stroke and COVID-19. COVID-19 patients had higher rates of intracranial bleeding complications and worse clinical outcomes after treatment compared to non-COVID-19 patients.

NEUROLOGY (2023)

Article Clinical Neurology

Apical pulmonary lesions suspected of malignancy visible on neck CT angiography performed for acute stroke: Prevalence, treatment, and clinical implications - the PLEURA study

Tolga D. Dittrich, Mara Aujesky, Salome Rudin, Annaelle Zietz, Benjamin Wagner, Alexandros Polymeris, Valerian L. Altersberger, Tim Sinnecker, Henrik Gensicke, Stefan T. Engelter, Philippe Lyrer, Viviane Hess, Raoul Sutter, Christian H. Nickel, Leo H. Bonati, Urs Fischer, Marios Psychogios, Mira Katan, Gian Marco De Marchis

Summary: This study retrospectively included data from 2715 patients with acute stroke and found that 5.9% (161/2715) of patients had pulmonary lesions on CTA. Approximately one-third of these lesions (58/161) were suspicious for malignancy. Further investigation confirmed primary or secondary pulmonary malignancy in two-thirds of patients (12/16) and they received oncologic therapy.

EUROPEAN STROKE JOURNAL (2023)

Review Clinical Neurology

Internal carotid artery dissection in a patient with hemophilia A: a case report and literature review

Salvatore Iacono, Roberta Baschi, Lucia Di Giorgi, Cesare Gagliardo, Alessandro Pezzini, Roberto Monastero

Summary: Spontaneous cervical artery dissection (sCeAD) is the most common cause of ischemic stroke at a young age. Hemophilia A, an X-linked condition that leads to spontaneous bleeding, may also be associated with arterial dissection. However, the relationship between these two diseases and the best antithrombotic treatment option for hemophilia patients with arterial dissection have not been studied extensively.

NEUROLOGICAL SCIENCES (2023)

Article Clinical Neurology

Iatrogenic cerebral amyloid angiopathy: An illustrative case of a newly introduced disease

Benedetta Storti, Isabella Canavero, Maria Magdalena Gabriel, Antonella Capozza, Nicola Rifino, Mario Stanziano, Luca Tagliabue, Anna Bersano

Summary: Iatrogenic cerebral amyloid angiopathy (iCAA) is a specific type of cerebral amyloid angiopathy, and its diagnosis is increasing. It is hypothesized that iCAA may occur as a late consequence of past neurosurgical interventions involving dural patch grafts. Although positron emission tomography (PET) scans and beta-amyloid levels in cerebrospinal fluid (CSF) are auxiliary criteria, the definite diagnosis still relies on histopathological examination.

EUROPEAN JOURNAL OF NEUROLOGY (2023)

Editorial Material Biochemistry & Molecular Biology

Pathophysiology and Treatment of Stroke: Present Status and Future Perspectives

Anna Bersano, Laura Gatti

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Cardiac & Cardiovascular Systems

Genetic Insights on the Relation of Vascular Risk Factors and Cervical Artery Dissection

Quentin Le Grand, Leslie Ecker Ferreira, Tiina M. Metso, Sabrina Schilling, Turgut Tatlisumak, Caspar Grond-Ginsbach, Stefan T. Engelter, Philippe Lyrer, Jennifer J. Majersik, Bradford B. Worrall, Andrew M. Southerland, Hugh S. Markus, Mark Lathrop, Vincent Thijs, Didier Leys, Philippe Amouyel, Jean Dallongeville, Martin Dichgans, Alessandro Pezzini, Anna Bersano, Muralidharan Sargurupremraj, Stephanie Debette

Summary: There is a causal relationship between high blood pressure and the risk and recurrence of cervical artery dissections. Beta-blockers may lower the risk of cervical artery dissections, while calcium-channel blockers may lower the risk of non-cervical artery dissections.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2023)

Article Clinical Neurology

IV Thrombolysis With or Without Endovascular Treatment for Suspected Ischemic Stroke in Patients With Intracranial Tumors

Katharina Seystahl, Nicolas Martinez-Majander, Alexander Salerno, Morin Beyeler, Hebun Erdur, Joao Pedro Marto, Christian Hametner, Marialuisa Zedde, Alessandro Pezzini, Ronen Leker, Valerian Altersberger, Gianluca Costamagna, Miguel Serodio, Ludovica Migliaccio, Rosario Pascarella, Andrea Zini, Laura Mannismaki, Yannick Bejot, Simon Jung, Henrik Gensicke, Visnja Padjen, Peter A. Ringleb, Christian Nolte, Mirjam R. Heldner, Patrik Michel, Stefan T. Engelter, Sami Curtze, Michael Weller, Susanne Wegener

Summary: This study analyzed data from the European TRISP collaboration to assess the frequency of symptomatic and fatal intracranial hemorrhage (ICH) in patients with intracranial tumors who underwent intravenous thrombolysis (IVT) for suspected ischemic stroke. The results showed a potential high risk of symptomatic ICH in patients with tumors of the pituitary region and suggested that these findings could guide individual treatment decisions in this population.

NEUROLOGY (2023)

Article Clinical Neurology

Cerebral microbleeds and asundexian in non-cardioembolic ischemic stroke: Secondary analyses of the PACIFIC-STROKE randomized trial

Pargol Balali, Robert G. Hart, Eric E. Smith, Feryal Saad, Pablo Colorado, Robin Lemmens, Gian Marco De Marchis, Valeria Caso, Lizhen Xu, Laura Heenan, Stuart J. Connolly, Hardi Mundl, Ashkan Shoamanesh

Summary: This study aimed to investigate the effects of the factor-XIa inhibitor asundexian on the development of new microbleeds in non-cardioembolic ischemic stroke patients. The results showed that asundexian treatment was not associated with the development of microbleeds and had a lower occurrence of adverse outcomes such as new microbleeds and hemorrhagic transformation in patients with microbleeds.

INTERNATIONAL JOURNAL OF STROKE (2023)

Article Health Care Sciences & Services

A Network of Sites and Upskilled Therapists to Deliver Best-Practice Stroke Rehabilitation of the Arm: Protocol for a Knowledge Translation Study

Leeanne M. Carey, Liana S. Cahill, Jannette M. Blennerhassett, Michael Nilsson, Natasha A. Lannin, Vincent Thijs, Susan Hillier, Dominique A. Cadilhac, Geoffrey A. Donnan, Meg E. Morris, Leonid Churilov, Marion Walker, Shanthi Ramanathan, Michael Pollack, Esther May, Geoffrey C. Cloud, Sharon Mcgowan, Tissa Wijeratne, Marc Budge, Fiona Mckinnon, John Olver, Toni Hogg, Michael Murray, Brendon Haslam, Irene Koukoulas, Brittni Nielsen, Yvonne Mak-Yuen, Megan Turville, Cheryl Neilson, Anna Butler, Joosup Kim, Thomas A. Matyas

Summary: This study aims to increase access to evidence-based upper-limb rehabilitation for stroke survivors and improve their outcomes through the establishment of a national partnership. The research utilizes a knowledge transfer intervention to enhance therapists' skills and guide the implementation of SENSe therapy. Outcomes include successful delivery of therapy, improved somatosensory function, and better performance in self-selected activities and quality of life.

HEALTHCARE (2023)

Correction Clinical Neurology

ESO guideline for the management of extracranial and intracranial artery dissection (vol 6, R39, 2021)

S. Debette, M. Mazighi, P. Bijlenga

EUROPEAN STROKE JOURNAL (2023)

No Data Available